| Original language | English |
|---|---|
| Pages (from-to) | 168-169 |
| Number of pages | 2 |
| Journal | Cancer Letters |
| Volume | 342 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 28 Jan 2014 |
Cite this
Panayiotidis, M. I. (2014). Cancer epigenetics as biomarkers of clinical significance. Cancer Letters, 342(2), 168-169. https://doi.org/10.1016/j.canlet.2013.10.027
@article{7f9f0131a04a4295842362857424bde0,
title = "Cancer epigenetics as biomarkers of clinical significance",
author = "Panayiotidis, {Mihalis I}",
year = "2014",
month = "1",
day = "28",
doi = "10.1016/j.canlet.2013.10.027",
language = "English",
volume = "342",
pages = "168--169",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",
}
Panayiotidis, MI 2014, 'Cancer epigenetics as biomarkers of clinical significance', Cancer Letters, vol. 342, no. 2, pp. 168-169. https://doi.org/10.1016/j.canlet.2013.10.027
Cancer epigenetics as biomarkers of clinical significance. / Panayiotidis, Mihalis I.
In: Cancer Letters, Vol. 342, No. 2, 28.01.2014, p. 168-169.Research output: Contribution to journal › Editorial
TY - JOUR
T1 - Cancer epigenetics as biomarkers of clinical significance
AU - Panayiotidis, Mihalis I
PY - 2014/1/28
Y1 - 2014/1/28
U2 - 10.1016/j.canlet.2013.10.027
DO - 10.1016/j.canlet.2013.10.027
M3 - Editorial
VL - 342
SP - 168
EP - 169
JO - Cancer Letters
JF - Cancer Letters
SN - 0304-3835
IS - 2
ER -
Panayiotidis MI. Cancer epigenetics as biomarkers of clinical significance. Cancer Letters. 2014 Jan 28;342(2):168-169. https://doi.org/10.1016/j.canlet.2013.10.027